60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026

WASHINGTON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne disease, announced today the planned expansion of the Company’s sales and marketing initiatives after encouraging results from a 6-month commercial pilot that showed an overall increase in product sales. The positive outcome points to increasing market demand for ARAKODA^® among prescribers.

Read more at globenewswire.com